TB advocates encourage the Ministry of Health in Peru to develop country guidance on the use of delamanid for the treatment of drug-resistant TB, a first step to facilitating access.

TB advocates addressed the University of Limpopo and Sefako Makgatho Health Science University demanding the immediate release of funds for the NeXT study.

TB activists urge the Drug Controller General of India to withdraw GeneDrive test for TB from the Indian market.

TB advocates urge the Ministry of Health in Cote d’Ivoire to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.

Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.

Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.

Take Action for TB Today! Sign and share this petition now: https://uaem.wufoo.com/forms/z1dxtbgq0ieib3a/

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.